{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:37:56Z","timestamp":1760985476808,"version":"3.41.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T00:00:00Z","timestamp":1471824000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["SpringerPlus"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s40064-016-3079-3","type":"journal-article","created":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T12:44:48Z","timestamp":1471869888000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Successful management of dexmedetomidine for postoperative intensive care sedation in a patient with anti-NMDA receptor encephalitis: a case report and animal experiment"],"prefix":"10.1186","volume":"5","author":[{"given":"Daiki","family":"Yamanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Tateiwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabricio M.","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,22]]},"reference":[{"key":"3079_CR1","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0022-3565(24)35047-5","volume":"290","author":"P Andin\u00e9","year":"1999","unstructured":"Andin\u00e9 P, Widermark N, Axelsson R, Nyberg G, Olofsson U, Martensson E, Sandberg M (1999) Characterization of MK-801-induced behavior as a putative rat model of psychosis. J Pharmacol Exp Ther 290:1393\u20131408","journal-title":"J Pharmacol Exp Ther"},{"key":"3079_CR2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1213\/XAA.0000000000000003","volume":"2","author":"DK Broderick","year":"2014","unstructured":"Broderick DK, Raines DE, Nanji KC (2014) Total intravenous anesthesia using N-methyl-d-aspartate (NMDA) receptor-sparing drugs in a patient with anti-NMDA receptor encephalitis. A&A Case Rep 2:83\u201385","journal-title":"A&A Case Rep"},{"key":"3079_CR3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/ACO.0b013e328305e3ef","volume":"21","author":"DS Carollo","year":"2008","unstructured":"Carollo DS, Nossaman BD, Ramadhyani U (2008) Dexmedetomidine: a review of clinical applications. Curr Opin Anaesthesiol 21:457\u2013461","journal-title":"Curr Opin Anaesthesiol"},{"key":"3079_CR4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","volume":"10","author":"J Dalmau","year":"2011","unstructured":"Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R (2011) Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10:63\u201374","journal-title":"Lancet Neurol"},{"key":"3079_CR5","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/ALN.0b013e318286cf36","volume":"118","author":"V Degos","year":"2013","unstructured":"Degos V, Charpentier TL, Chhor V, Brissaud O, Lebon S, Schwendimann L, Bednareck N, Passemard S, Mantz J, Gressens P (2013) Neuroprotective effects of dexmedetomidine against glutamate agonist-induced neuronal cell death are related to increased astrocyte brain-derived neurotrophic factor expression. Anesthesiology 118:1123\u20131132","journal-title":"Anesthesiology"},{"key":"3079_CR6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/sj.mp.4000912","volume":"7","author":"NB Farber","year":"2002","unstructured":"Farber NB, Kim SH, Dikranian K, Jiang XP, Heinkel C (2002) Receptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity. Mol Psychiatry 7:32\u201343","journal-title":"Mol Psychiatry"},{"key":"3079_CR7","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/nrn2372","volume":"9","author":"NP Franks","year":"2008","unstructured":"Franks NP (2008) General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal. Nat Rev Neurosci 9:370\u2013386","journal-title":"Nat Rev Neurosci"},{"key":"3079_CR8","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","volume":"30","author":"EG Hughes","year":"2010","unstructured":"Hughes EG, Peng X, Gleichman AJ, Lai M, Zhou L, Tsou R, Parsons TD, Lynch DR, Dalmau J, Balice-Gordon RJ (2010) Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 30:5866\u20135875","journal-title":"J Neurosci"},{"key":"3079_CR9","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/sj.bjp.0701520","volume":"122","author":"JC Hunter","year":"1997","unstructured":"Hunter JC, Fontana DJ, Hedley LR, Jasper JR, Lewis R, Link RE, Secchi R, Sutton J, Eglen RM (1997) Assessment of the role of \u03b12-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice. Br J Pharmacol 122:1339\u20131344","journal-title":"Br J Pharmacol"},{"key":"3079_CR10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2044.2011.06707.x","volume":"66","author":"H Kawano","year":"2011","unstructured":"Kawano H, Hamaguchi E, Kawahito S, Tsutsumi YM, Tanaka K, Kitahata H, Oshita S (2011) Anaesthesia for a patient with paraneoplastic limbic encephalitis with ovarian teratoma: relationship to anti-N-methyl-d-aspartate receptor antibodies. Anaesthesia 66:515\u2013518","journal-title":"Anaesthesia"},{"key":"3079_CR11","first-page":"111","volume":"26","author":"JL Kruse","year":"2014","unstructured":"Kruse JL, Jeffrey JK, Davis MC, Dearlove J, IsHak WW, Brooks JO III (2014) Anti-N-methyl-d-aspartate receptor encephalitis: a targeted review of clinical presentation, diagnosis, and approaches to psychopharmacologic management. Ann Clin Psychiatry 26:111\u2013119","journal-title":"Ann Clin Psychiatry"},{"key":"3079_CR12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2253-14-5","volume":"14","author":"FX Lap\u00e9bie","year":"2014","unstructured":"Lap\u00e9bie FX, Kennel C, Magy L, Projetti F, Honnorat J, Pichon N, Vignon P, Fran\u00e7ois B (2014) Potential side effect of propofol and sevoflurane for anesthesia of anti-NMDA-R encephalitis. BMC Anesthesiol 14:5","journal-title":"BMC Anesthesiol"},{"key":"3079_CR13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2004.08.044","volume":"502","author":"D Ma","year":"2004","unstructured":"Ma D, Hossain M, Rajakumaraswamy N, Arshad M, Sanders RD, Franks NP, Maze M (2004) Dexmedetomidine produces its neuroprotective effect via the alpha 2A-adrenoceptor subtype. Eur J Pharmacol 502:87\u201397","journal-title":"Eur J Pharmacol"},{"key":"3079_CR14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/978-3-540-74806-9_16","volume":"182","author":"KT Olkkola","year":"2008","unstructured":"Olkkola KT, Ahonen J (2008) Midazolam and other benzodiazepines. Handb Exp Pharmacol 182:335\u2013360","journal-title":"Handb Exp Pharmacol"},{"key":"3079_CR15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn3504","volume":"14","author":"P Paoletti","year":"2013","unstructured":"Paoletti P, Bellone C, Zhou Q (2013) NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci 14:383\u2013400","journal-title":"Nat Rev Neurosci"},{"key":"3079_CR16","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.autrev.2012.03.001","volume":"11","author":"HE Peery","year":"2012","unstructured":"Peery HE, Day GS, Dunn S, Fritzler MJ, Pr\u00fcss H, De Souza C, Doja A, Mossman K, Resch L, Xia C, Sakic B, Belbeck L, Foster WG (2012) Anti-NMDA receptor encephalitis. The disorder, the diagnosis and the immunobiology. Autoimmun Rev 11:863\u2013872","journal-title":"Autoimmun Rev"},{"key":"3079_CR17","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1213\/ANE.0b013e31822b8a7d","volume":"113","author":"PG Pryzbylkowski","year":"2011","unstructured":"Pryzbylkowski PG, Dunkman WJ, Liu R, Chen L (2011) Case report: anti-N-methyl-d-aspartate receptor encephalitis and its anesthetic implications. Anesth Analg 113:1188\u20131191","journal-title":"Anesth Analg"},{"key":"3079_CR18","first-page":"431","volume":"82","author":"RW Simon","year":"2014","unstructured":"Simon RW (2014) Anesthetic management and implications of pediatric patients with a diagnosis of anti-N-methyl-d-aspartate receptor encephalitis: two case reports. AANA J 82:431\u2013436","journal-title":"AANA J"},{"key":"3079_CR19","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1017\/S1461145714000509","volume":"17","author":"I Sukhanov","year":"2014","unstructured":"Sukhanov I, Espinoza S, Yakovlev DS, Hoener MC, Sotnikova TD, Gainetdinov RR (2014) TAAR1-dependent effects of apomorphine in mice. Int J Neuropsychopharmacol 17:1683\u20131693","journal-title":"Int J Neuropsychopharmacol"},{"key":"3079_CR20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I, Armangu\u00e9 T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez E, Aguilar E, Gresa-Arribas N, Ryan-Florance N, Torrents A, Saiz A, Rosenfeld MR, Balice-Gordon R, Graus F, Dalmau J (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12:157\u2013165","journal-title":"Lancet Neurol"},{"key":"3079_CR21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.autrev.2013.10.016","volume":"13","author":"MH Coevorden-Hameete van","year":"2014","unstructured":"van Coevorden-Hameete MH, de Graaff E, Titulaer MJ, Hoogenraad CC, Sillevis Smitt PA (2014) Molecular and cellular mechanisms underlying anti-neuronal antibody mediated disorders of the central nervous system. Autoimmun Rev 13:299\u2013312","journal-title":"Autoimmun Rev"}],"container-title":["SpringerPlus"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40064-016-3079-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40064-016-3079-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40064-016-3079-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T11:37:12Z","timestamp":1749555432000},"score":1,"resource":{"primary":{"URL":"http:\/\/springerplus.springeropen.com\/articles\/10.1186\/s40064-016-3079-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,22]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["3079"],"URL":"https:\/\/doi.org\/10.1186\/s40064-016-3079-3","relation":{},"ISSN":["2193-1801"],"issn-type":[{"type":"electronic","value":"2193-1801"}],"subject":[],"published":{"date-parts":[[2016,8,22]]},"article-number":"1380"}}